News & Events

Below is a selection of our news & events (PDFs).

If your browser forces the PDF to download instead of viewing it change the action in your browser preferences. Download Acrobat Reader by clicking the icon.

April 17, 2024

Patient Celebrates 10 Years Since SynCardia's Total Artificial Heart

Tucson, AZ, April 17, 2024 - SynCardia Systems, LLC., a Picard Medical Company, proudly commemorates Steve William’s remarkable 10-year journey since receiving a SynCardia Total Artificial Heart (STAH). Steve underwent the STAH implantation procedure on April 17, 2014. Read More >

March 11, 2024

Patent Covering Innovative Total Artificial Heart Design Granted to SynCardia 

Tucson, AZ, March 11th 2024, SynCardia Systems, LLC., a Picard Medical Company, is thrilled to announce that the U.S. Patent and Trademark Office (USPTO) has granted a patent for groundbreaking next generation total artificial heart designs under application “Next Generation Total Artificial Heart”. Read More >

February 5, 2024

SynCardia Systems LLC Announces Publication of Patent Application Covering Innovative Total Artificial Heart Design 

Tucson, AZ, February 5th  2024, SynCardia Systems, LLC., a Picard Medical Company, proudly announces that the U.S. Patent and Trademark Office (USPTO) has allowed claims of its groundbreaking patent application “Next Generation Total Artificial Heart” covering next generation total artificial heart designs. Read More >

November 29, 2023

Baylor Hospital’s recent implant of the SynCardia Total Artificial Heart

Team at Baylor University Medical Center Dallas TX recently implanted and bridged a young woman to heart transplantation. Read More >

August 21, 2023

Connecting with Industry Leaders: Our Journey at ASAIO 2023

On the heels of the FDA approval of the new software updates for the Freedom Driver, SynCardia was out in force at the 2023 Annual Conference of the American Society of Artificial Internal Organs (ASAIO). Read More >

August 14, 2023

Altitude Acquisition Corp. files preliminary proxy statement with SEC for merger with Picard Medical, Inc. and its subsidiary, SynCardia Systems LLC

A preliminary proxy statement has been filed with the Securities and Exchange Commission by Altitude Acquisition Corp. for its proposed merger with Picard Medical, Inc and SynCardia Systems LLC. Read More >

August 1, 2023

Showcased our virtual tour at the Heart  Hackathon

As a platinum sponsor of the HeartHackathon, Tucson, Arizona-based SynCardia is demonstrating its commitment to education, innovation, and to advancing the field of artificial heart technologies. Read More >

July 11, 2023

SynCardia Updates Total Artificial Heart Labeling with Real World Data

SynCardia Systems, LLC., a Picard Medical Company, today announced that the U.S. Food and Drug Administration (FDA) has approved an update of the SynCardia TAH label with real world data further confirming the safety and performance of the Companion 2 Driver. Read More >

July 7, 2023

Randy’s Remarkable Jour-ney: Celebrating the 10-Year Anniversary Since Receiving SynCardia’s Totally Artificial Heart

Celebrating Randy’s incredible 10-year anniversary since receiving a Total Artificial Heart! Despite facing immense challenges, Randy has shown us what it means to live life to the fullest and embrace every opportunity with unwavering determination. Read More >

June 28, 2023

SynCardia Welcomes  Patrick NJ Schnegelsberg as CEO

We are excited about the announcement that Patrick NJ Schnegelsberg is the new Chief Executive Officer of SynCardia Systems, LLC the parent company of Picard Medical, Inc. A global leader in mechanical heart replacement technology. Read More >

June 1, 2023

SynCardia Participates in Heart Walk 2023

The SynCardia team eagerly walked the 5 km course, aiming to raise awareness and funds for heart disease while fostering a sense of community. Read More >

May 17, 2023

International Society for Heart and Lung Transplan-tation (ISHLT) conference 2023!

Close On The Heels Of The Recent FDA Approval Of The Software Upgrades To The Freedom Driver, Team SynCardia Was Out In Force At The Annual Conference Of International Society For Heart And Lung Transplantation (ISHLT). Read More >

April 24, 2023

Picard Medical and its Subsidiary, SynCardia Systems, a Pioneer in Total Artificial Heart Technology, to Become a Publicly Traded  Company via Merger with Altitude Acquisition Corp.

SynCardia Manufactures and Distributes the First-and-Only Commercially Available and FDA Approved Total Artificial Heart. SynCardia is Entering a Rapid Growth Phase Supported by New Product Development, Label Expansion, and International Growth. Read More >

February 25, 2023

FDA approves significant Freedom Portable Driver software upgrades from SynCardia Systems Inc. 

SynCardia Systems LLC is pleased to announce that the US Food and Drug Administration (FDA) has approved significant software upgrades to the Freedom Portable Driver. Read More >

Freedom is a TradeMark of SynCardia Systems, LLC

SynCardia Systems, LLC

1992 E. Silverlake Rd. Tucson, AZ 85713
+1 520-545-1234 |


SynCardia Systems, LLC – a Picard Medical Company

The SynCardia Total Artificial Heart is a treatment option for cardiac transplant-eligible patients at risk of imminent death from biventricular failure.

Medical Advice Disclaimer
The information, including but not limited to, text, graphics, images and other material contained on this website are for informational purposes only. No material on this site is intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or a qualified health care provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of information you have read on this website.

©  SynCardia Systems, LLC | All rights reserved.

This website makes use of cookies. Please see our Privacy & Cookie Policy for details.